Table 2.
Factors associated with entry in care (2007–2010) and retention in care (2010–2011) among HIV-infected patients in Belgium
| Entry in care | Retention in care | |||||
|---|---|---|---|---|---|---|
| Characteristic | Entry | OR for no entry (95 % CI) | AORa for no entry (95 % CI) | Retained | OR for no retention (95 % CI) | AORa for no retention (95 % CI) |
| Sex | ||||||
| Male | 88.8 % | 1 | 1 | 92.9 % | 1 | 1 |
| Female | 83.9 % | 1.52 (1.26–1.83) | 0.83 (0.58–1.19) | 91.0 % | 1.30 (1.13–1.49) | 0.82 (0.66–1.04) |
| Age at diagnosis | ||||||
| <40 years | 87.1 % | 1 | 1 | 94.1 % | 1 | 1 |
| ≥40 years | 87.0 % | 1.01 (0.84–1.22) | 0.91 (0.67–1.24) | 93.9 % | 1.02 (0.86–1.23) | 1.01 (0.81–1.25) |
| Way of transmission | ||||||
| Heterosexual | 91.4 % | 1 | 1 | 91.8 % | 1 | 1 |
| MSM | 94.6 % | 0.61 (0.45–0.82) | 0.97 (0.62–1.51) | 95.1 % | 0.56 (0.45–0.70) | 0.59 (0.45–0.78) |
| IDU | 85.7 % | 1.77 (0.85–3.66) | 1.69 (0.71–4.05) | 85.8 % | 1.87 (1.22–2.86) | 2.01 (1.27–3.17) |
| Nationality | ||||||
| Belgian | 95.7 % | 1 | 1 | 95.8 % | 1 | 1 |
| SSA | 88.8 % | 2.82 (2.05–3.88) | 3.36 (2.14–5.27) | 92.8 % | 1.74 (1.42–2.12) | 1.50 (1.16–1.93) |
| European | 88.5 % | 2.91 (1.94–4.35) | 2.43 (1.52–3.90) | 91.7 % | 2.03 (1.48–2.78) | 1.88 (1.35–2.61) |
| Other | 88.0 % | 3.04 (1.93–4.79) | 3.01 (1.81–5.01) | 93.4 % | 1.58 (1.09–2.29) | 1.43 (0.97–2.10) |
| Reason for testing | ||||||
| Patient’s request | 93.3 % | 1 | 1 | 95.0 % | 1 | 1 |
| Clinical arguments | 93.5 % | 0.97 (0.69–1.36) | 0.90 (0.61–1.32) | 94.3 % | 1.15 (0.88–1.50) | 1.01 (0.77–1.34) |
| Preoperative | 79.2 % | 3.68 (2.01–6.73) | 3.91 (2.03–7.53) | 93.1 % | 1.42 (0.82–2.46) | 1.31 (0.74–2.32) |
| Other | 90.3 % | 1.51 (1.04–2.20) | 0.98 (0.63–1.53) | 92.9 % | 1.46 (1.09–1.95) | 1.20 (0.89–1.63) |
| CD4 at first visit | ||||||
| CD4≥350 | / | / | / | 93.2 % | 1 | 1 |
| CD4≥200 & <350 | / | / | / | 91.3 % | 1.30 (0.90–1.86) | 1.12 (0.74–1.69) |
| CD4 < 200 | / | / | / | 91.5 % | 1.28 (0.87–1.86) | 1.16 (0.76–1.77) |
| Time since HIV diagnosis | ||||||
| <1 year | / | / | / | 90.0 % | 1 | 1 |
| 1 – <5 years | / | / | / | 93.9 % | 0.59 (0.47–0.74) | 0.55 (0.42–0.72) |
| 5 – <10 years | / | / | / | 95.4 % | 0.44 (0.34–0.56) | 0.42 (0.32–0.56) |
| ≥10 years | / | / | / | 95.7 % | 0.41 (0.32–0.51) | 0.40 (0.31–0.53) |
| ART | ||||||
| Not on ART end 2009 | / | / | / | 93.5 % | 1 | 1 |
| On ART end 2009 | / | / | / | 96.6 % | 0.50 (0.39–0.64) | 0.45 (0.34–0.61) |
p < 0.05, statistically significant variables presented in boldface
aAdjusted for sex, age at diagnosis, nationality, way of transmission